期刊文献+

F型沙眼衣原体主外膜蛋白基因omp1原核表达及其序列分析

Prokaryotic expression of omp1 gene encoding the major outer membrane protein of Chlamydia trachomatis serovar F and its sequence analysis
下载PDF
导出
摘要 目的对F型沙眼衣原体主外膜蛋白(MOMP)基因进行原核表达,获得omp1基因重组蛋白,并对克隆到的基因进行序列分析,为F型沙眼衣原体的诊断及疫苗研究奠定基础。方法利用PCR技术从沙眼衣原体阳性病人尿道拭子标本中扩增omp1基因,分析序列,并定向克隆入原核表达载体pGEX-5X3中,与GST进行融合表达。结果对克隆到的沙眼衣原体omp1基因进行序列分析,基因序列与F型沙眼衣原体F/IC-CAL3相似性达99%,构建Omp1-pGEX-5X3重组质粒,omp1与GST融合表达。结论成功构建F型沙眼衣原体omp1基因原核表达系统,得到重组蛋白,为沙眼衣原体疫苗的研究和临床检测试剂盒的研制打下基础。 To express the gene encoding the major outer membrane protein (MOMP) of Chlamydia trachomatis serovar. F to obtain the ompl gene recombinant protein for use in diagnosis and vaccine development for C. trachomatis infection, the ompl gene was amplified from the genome of C. trachomatis from urethra swab sample of trachoma patients by PCR, sequenced and cloned to Prokaryotic expression vector pGEX-SX3 for fusion expression with GST. The cloned ompl gene was then subjected to sequence analysis and it was found that the sequence identity of ornpl gene with F/IC-CAL3 of C. trachornatis serovar F approached up to 99 %. Also, the Ompl-pGEX-SX3 recombinant plasmid was successfully constructed. It is apparent that the prokaryotic expression system for the ompl gene is established and the recombinant protein obtained, thus providing the foundation for the studies on trachoma vaccine and preparation of the diagnostic kids for trachoma.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2008年第11期1052-1056,共5页 Chinese Journal of Zoonoses
基金 国家自然科学基金(No.30400258)
关键词 F型沙眼衣原体 omp1基因 原核表达 序列分析 Chlamydia trachomatis serovar F ompl gene prokaryotic expression sequence analysis
  • 相关文献

参考文献14

  • 1Piot P, Islam MQ. Sexually transmitted diseases in the 1990s. Global epidemiology and challenges for control[J]. Sex Transm Dis, 1994, 21 (2 Suppl): 7-13.
  • 2Paavonen J, Puolakkainen M, Paukku M,et al. Cost benefits analysis of first void urine Chlamydia traehomatis screening program[J].Obstet Gynecol, 1998, 92(2):292-298.
  • 3World Health Organization Department of HIV/ AIDS. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates[R]. Geneva : World Health Organization, 2001:10 -13.
  • 4Somani J, Bhullar VB, Workowski K A,et al. Multiple drug resistant Chlamydla trachomatis associated with clinical treatmentfailure[J].J Infect Dis, 2000, 181 (4):1421-1427.
  • 5Sylvan S, Von Krogh G, Tiveljung A,et al. Screening and genotyping of genital Chlamydia trachomatis in urine specimens from male and female clients of youth health centers in Stockholm County[J]. Sex Transm Dis, 2002, 29 (7) : 379-386.
  • 6Sturm Ramire Z K, Brumblay H, Diop K,et al. Molecular epidemiology of genital Chlamydia trachomatis infection in high risk women in Senegal , West Africa[J].J Clin Microbiol, Z000, 38(1):138-145.
  • 7Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydla trachomatis and risk for development of cervical squamous cell carcinoma[J]. JAMA, 2001, 285 (1): 47-51.
  • 8Bachmaier K, Neu N, LM de la Maza,et al. Chlamydia infections and heart disease linked through antigenic mimicry[J]. Science, 1999, 283(5406) : 1335-1336.
  • 9Solomon A W, Peeling R W, Foster A, et al. Diagnosis and Assessment of Trachoma[J].Clin. Mierobiol. Rev. 2004, 17(4): 982-1011.
  • 10Xing Gao, Xiaag-Sheng Chen,Yue-Ping Yin,et ai. Distribution Study of Chlamydia trachomatis serovars among high-risk women in china performed using PCR-restriction fragment length polymorphism genotyping[J]. J Clin Microbiol, 2007, 45(4) : 1185-1189.

二级参考文献10

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部